National Research (NASDAQ:NRC) Shares Pass Above Two Hundred Day Moving Average – Here’s Why

National Research Corporation (NASDAQ:NRC)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $15.33 and traded as high as $19.81. National Research shares last traded at $19.49, with a volume of 51,825 shares traded.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of National Research in a research report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

National Research Price Performance

The stock has a market cap of $446.86 million, a PE ratio of 28.17 and a beta of 0.47. The company has a debt-to-equity ratio of 5.31, a quick ratio of 0.53 and a current ratio of 0.53. The business has a 50 day moving average price of $17.14 and a two-hundred day moving average price of $15.34.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Monday, October 27th. The company reported $0.23 EPS for the quarter. National Research had a return on equity of 98.26% and a net margin of 11.76%.The business had revenue of $34.61 million for the quarter.

National Research Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date was Friday, December 26th. This is a positive change from National Research’s previous quarterly dividend of $0.12. National Research’s dividend payout ratio (DPR) is presently 91.43%.

Institutional Trading of National Research

A number of large investors have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC purchased a new position in National Research in the first quarter valued at about $118,000. AQR Capital Management LLC increased its stake in shares of National Research by 168.6% during the 1st quarter. AQR Capital Management LLC now owns 108,134 shares of the company’s stock worth $1,384,000 after purchasing an additional 67,882 shares during the last quarter. Jane Street Group LLC raised its holdings in shares of National Research by 394.2% in the 1st quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock worth $671,000 after purchasing an additional 41,806 shares during the period. Strs Ohio purchased a new position in National Research in the first quarter valued at approximately $33,000. Finally, Rhumbline Advisers lifted its stake in National Research by 4.5% in the first quarter. Rhumbline Advisers now owns 22,204 shares of the company’s stock valued at $284,000 after purchasing an additional 946 shares during the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.